The MGH-Harvard Center for Addiction Medicine delivers clinical evaluation, consultation, and study-related clinical care in a multidisciplinary setting.
Our Staff
John F. Kelly, Ph.D.Associate Director/
Principal Investigator
Associate Professor
Harvard Medical School
Gladys Pachas, M.D.Instructor
Harvard Medical Schooll
Luke Stoeckel, Ph.D.Director of Clinical
Neuroscience /
Principal Investigator Assistant Professor
Harvard Medical School
Bettina Hoeppner, Ph.D.Assistant Professor
Harvard Medical School
Jodi Gilman, Ph.D.Instructor Harvard Medical School
Mireya Nadal, M.D., Ph.D.Instructor/Assistant in Research
Brian Schulman, M.DInstructor/Assistant in Research
Zev Schuman-OlivierClinical Fellow
Brandon G. Bergman, Ph.D.Research Fellow
Allison K. Labbe, Ph.D.Research Fellow
Peter Bannigan, M.B.A.Financial Manager
Susanne Hoeppner, Ph.D.Data Analyst
Heather Burrell, B.A.Research Coordinator
Caroline Chan, B.A. Research Coordinator
Julie Cristello, B.A.Research Coordinator
Elisabeth Grasser, B.A.Research Coordinator
Claire Greene, M.P.H.Research Coordinator
Veselina Hristova, B.A.Research Coordinator
Vicenta Hudziak, B.A.Research Coordinator
Alexandra Laffer, B.S.Research Coordinator
Julia Stern, B.A.Research Coordinator
Jonathan Watson, M.A.Research Coordinator
Erika Weisz, B.A.Research Coordinator
Julie Yeterian, M.A.Research Coordinator
Featured Publication: Kelly, J. & White, W. (Eds., 2011).
Addiction recovery management: Theory, research and practice.
New York: Springer Science.
To order this online: Click Here
Biography for Dr. A. Eden Evins:
Dr. Evins completed her residency in adult psychiatry at the Massachusetts Mental Health Center and Longwood Psychiatry Residency Training Program, where she was Chief Resident. She conducted a fellowship in molecular biology at the Mailman Research Center of McLean Hospital and a second fellowship in clinical research at the Massachusetts General Hospital.
Dr. Evins became the Director of the MGH Center for Addiction Medicine and completed a Masters in Public Health with a concentration in Clinical Effectiveness at the Harvard School of Public Health in 2005. She has been an active member of the MGH Schizophrenia and Depression Clinical and Research Program since 1995.
Dr. Evins' research interests include pharmacotherapy for nicotine dependence, negative symptoms of schizophrenia, co-occurring psychiatric and substance use disorders and cognitive dysfunction in schizophrenia. Additionally, she is studying the effects of various medications on reward responsiveness and other potential biomarkers of vulnerability to addiction and of treatment response.
She has authored articles, book chapters, and reviews concerning topics in this field. Her articles are published in scientific journals, such as American Journal of Psychiatry, Neuropsychopharmacology, Biological Psychiatry, Journal of Clinical Psychopharmacology, and Journal of Neural Transmission. Dr. Evins has twice been the recipient of the National Alliance for Research on Schizophrenia and Affective Disorders Young Investigator Award, and has been awarded the New Clinical Drug Evaluation Unit Award for Young Investigators sponsored by the National Institute of Mental Health, the Massachusetts Department of Public Health Young Investigator Award and two career development awards from NIDA.
She is currently supported by six major grants from the National Institutes of Drug Abuse for her work testing novel therapies for nicotine dependence in the general population and in those with co-occuring psychiatric disorders.
Biography for Dr. John Kelly:Dr. Kelly is an Associate Professor in Psychiatry at Harvard Medical School, the founder and Director of the Recovery Research Institute at the Massachusetts General Hospital (MGH), the Program Director of the Addiction Recovery Management Service (ARMS) and the Associate Director of the Center for Addiction Medicine at MGH.
Dr. Kelly is President Elect of the American Psychological Association (APA) Society of Addiction Psychology, and is also a Fellow of APA.
He has served as a consultant to U.S. federal agencies such as the White House Office of National Drug Control Policy (ONDCP), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the national Institutes of Health (NIH); to non-Federal institutions, such as the Betty Ford Institute and the Hazelden Foundation; and internationally to the British Parliament Drugs Misuse Taskforce.
He is currently an Associate Editor for the journals, Addiction, and the Journal of Substance Abuse Treatment. He has published more than 100 peer-reviewed articles, reviews, and chapters in the field of addiction. His clinical and research work has focused on addiction treatment and the recovery process which has included specific research on the effectiveness of mutual-help groups, such as Alcoholics Anonymous, as adjuncts to formal care.
His additional research endeavors have focused on the translation and implementation of evidence-based practice, addiction and criminal justice, addiction treatment theories and mechanisms of action, and reducing stigma associated with addiction. He is a licensed clinical psychologist actively working with individuals and families with alcohol and other drug use disorders.
